Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis

Detalles Bibliográficos
Autores principales: Meng, Jun, Wu, XiaoQin, Sun, Zhen, Xun, RenDe, Liu, MengSi, Hu, Rui, Huang, JianChao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530013/
https://www.ncbi.nlm.nih.gov/pubmed/34692553
http://dx.doi.org/10.3389/fonc.2021.768128
_version_ 1784586584735088640
author Meng, Jun
Wu, XiaoQin
Sun, Zhen
Xun, RenDe
Liu, MengSi
Hu, Rui
Huang, JianChao
author_facet Meng, Jun
Wu, XiaoQin
Sun, Zhen
Xun, RenDe
Liu, MengSi
Hu, Rui
Huang, JianChao
author_sort Meng, Jun
collection PubMed
description
format Online
Article
Text
id pubmed-8530013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85300132021-10-22 Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis Meng, Jun Wu, XiaoQin Sun, Zhen Xun, RenDe Liu, MengSi Hu, Rui Huang, JianChao Front Oncol Oncology Frontiers Media S.A. 2021-10-07 /pmc/articles/PMC8530013/ /pubmed/34692553 http://dx.doi.org/10.3389/fonc.2021.768128 Text en Copyright © 2021 Meng, Wu, Sun, Xun, Liu, Hu and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Meng, Jun
Wu, XiaoQin
Sun, Zhen
Xun, RenDe
Liu, MengSi
Hu, Rui
Huang, JianChao
Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title_full Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title_fullStr Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title_full_unstemmed Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title_short Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis
title_sort corrigendum: efficacy and safety of car-t cell products axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel for the treatment of hematologic malignancies: a systematic review and meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530013/
https://www.ncbi.nlm.nih.gov/pubmed/34692553
http://dx.doi.org/10.3389/fonc.2021.768128
work_keys_str_mv AT mengjun corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT wuxiaoqin corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT sunzhen corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT xunrende corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT liumengsi corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT hurui corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis
AT huangjianchao corrigendumefficacyandsafetyofcartcellproductsaxicabtageneciloleuceltisagenlecleucelandlisocabtagenemaraleucelforthetreatmentofhematologicmalignanciesasystematicreviewandmetaanalysis

Ejemplares similares